4519:TYO
Chugai Pharmaceutical Co Ltd
¥7,554.00
arrow_downward
-0.17%(-13.00) 1D
Jun 5, 3:30:00 PM GMT+9 · JPY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4519...
Open
¥7,649
High
¥7,658
Low
¥7,504
Mkt. cap
12.68T
Avg. vol.
3.46M
Volume
2.12M
Dividend
1.62%
Quarterly dividend
¥31
Ex-dividend date
Jun 29, 2026
P/E ratio
27.49
52-wk high
¥10,700
52-wk low
¥5,942
EPS
¥275
Shares outstanding
547.19M
No. of employees
5K
Open
¥7,649
High
¥7,658
Low
¥7,504
Mkt. cap
12.68T
Avg. vol.
3.46M
Volume
2.12M
Dividend
1.62%
Quarterly dividend
¥31
Ex-dividend date
Jun 29, 2026
P/E ratio
27.49
52-wk high
¥10,700
52-wk low
¥5,942
EPS
¥275
Shares outstanding
547.19M
No. of employees
5K
Analyst outlook
Analyst Ratings
Based on 10 analysts giving stock ratings to 4519 in the past 3 months
Buy
Buy
5
Hold
5
Sell
0
12 month forecast
Based on 10 Wall Street analysts offering 12 month price targets for 4519 in the last 3 months.
Highest
Current ¥7,554.00
¥13,500.00 (+78.71%)
Average
¥9,699.30 (+28.40%)
Lowest
¥8,000.00 (+5.90%)
News stories
From sources across the web
Simply Wall Street
·
18 hours ago
Assessing Chugai Pharmaceutical (TSE:4519) Valuation After Recent Share Price Weakness
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp
AI content may include mistakes. Learn more